Y. Lynn Wang

5.4k total citations
116 papers, 3.5k citations indexed

About

Y. Lynn Wang is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Y. Lynn Wang has authored 116 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Genetics, 46 papers in Molecular Biology and 35 papers in Pathology and Forensic Medicine. Recurrent topics in Y. Lynn Wang's work include Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (32 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Y. Lynn Wang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (32 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Y. Lynn Wang collaborates with scholars based in United States, China and United Kingdom. Y. Lynn Wang's co-authors include Ailin Guo, Morton Coleman, Nicholas C.P. Cross, Pin Lu, Jiao Ma, Michael Rosbash, Amy V. Jones, Richard T. Silver, Shuhua Cheng and Valérie Goguel and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Y. Lynn Wang

106 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Lynn Wang United States 35 1.8k 1.5k 1.1k 960 600 116 3.5k
Pearlie K. Epling‐Burnette United States 34 1.2k 0.7× 1.2k 0.8× 1.6k 1.5× 718 0.7× 1.9k 3.1× 113 4.0k
Alexander Egle Austria 35 1.2k 0.7× 2.0k 1.3× 586 0.6× 903 0.9× 1.2k 2.0× 153 4.2k
John Anastasi United States 37 1.1k 0.6× 2.6k 1.7× 2.9k 2.7× 642 0.7× 1.3k 2.2× 97 6.0k
Jérôme Tamburini France 31 535 0.3× 2.2k 1.4× 1.3k 1.2× 373 0.4× 359 0.6× 88 3.3k
Norma C. Gutiérrez Spain 41 1.2k 0.7× 3.3k 2.2× 3.4k 3.2× 925 1.0× 645 1.1× 179 5.6k
Eric Eldering Netherlands 46 2.5k 1.4× 2.2k 1.4× 1.0k 0.9× 1.3k 1.3× 2.5k 4.1× 170 6.0k
Lynn C. Moscinski United States 31 642 0.4× 2.8k 1.8× 1.3k 1.2× 785 0.8× 1.1k 1.8× 129 5.1k
Isabelle Dusanter‐Fourt France 38 706 0.4× 1.9k 1.2× 1.2k 1.1× 381 0.4× 1.3k 2.2× 83 4.8k
Mark Blick United States 28 589 0.3× 1.0k 0.7× 830 0.8× 374 0.4× 343 0.6× 55 2.8k
Keita Kirito Japan 29 585 0.3× 1.2k 0.8× 1.1k 1.0× 206 0.2× 375 0.6× 128 2.3k

Countries citing papers authored by Y. Lynn Wang

Since Specialization
Citations

This map shows the geographic impact of Y. Lynn Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Lynn Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Lynn Wang more than expected).

Fields of papers citing papers by Y. Lynn Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Lynn Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Lynn Wang. The network helps show where Y. Lynn Wang may publish in the future.

Co-authorship network of co-authors of Y. Lynn Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Lynn Wang. A scholar is included among the top collaborators of Y. Lynn Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Lynn Wang. Y. Lynn Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dong, Binhua, Zhen Lü, Tianjie Yang, et al.. (2025). Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study. The Lancet Regional Health - Western Pacific. 55. 101480–101480. 5 indexed citations
3.
4.
Şahin, Yavuz, Jianming Pei, Don A. Baldwin, et al.. (2024). Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review. Leukemia Research Reports. 21. 100465–100465.
5.
6.
Li, Yu, Zhengping Huang, Yan Yun, et al.. (2024). Progressive pseudorheumatoid dysplasia involving a novel CCN6 mutation: a case report. Frontiers in Immunology. 15. 1445420–1445420.
7.
Fernandez, Sandra V., Shilpa Rao, Fathima Sheriff, et al.. (2023). Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing. International Journal of Molecular Sciences. 24(21). 15779–15779. 2 indexed citations
8.
Şahin, Yavuz, Y. Lynn Wang, Jianming Pei, et al.. (2023). Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review. International Journal of Molecular Sciences. 25(1). 305–305. 3 indexed citations
9.
Wang, Y. Lynn, et al.. (2023). Nanomaterials Modulating the Fate of Dental-Derived Mesenchymal Stem Cells Involved in Oral Tissue Reconstruction: A Systematic Review. International Journal of Nanomedicine. Volume 18. 5377–5406. 6 indexed citations
10.
Nejati, Reza, et al.. (2023). Isochromosome 7p, i(7)(p10): A rare AML, myelodysplasia-related entity. Leukemia Research Reports. 20. 100387–100387.
11.
Nejati, Reza, Pin Lu, Don A. Baldwin, et al.. (2023). Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL). Molecular Case Studies. 9(4). a006283–a006283. 3 indexed citations
12.
Xue, Liyan, Yuan Li, Lili Jiang, et al.. (2023). Concordance between four PD-L1 immunohistochemical assays and 22C3 pharmDx assay in esophageal squamous cell carcinoma in a multicenter study. SHILAP Revista de lepidopterología. 4(2). 162–168.
13.
Lee, Jimmy & Y. Lynn Wang. (2020). Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia. Journal of Molecular Diagnostics. 22(9). 1114–1125. 20 indexed citations
14.
Ming, Mei, Wenjun Wu, Bingqing Xie, et al.. (2018). XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Molecular Cancer Therapeutics. 17(12). 2564–2574. 36 indexed citations
15.
Coffey, Greg, Jiajia Feng, Anjali Pandey, et al.. (2018). Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clinical Cancer Research. 25(4). 1174–1184. 29 indexed citations
16.
Wang, Y. Lynn, Mei Ming, Bingqing Xie, et al.. (2017). XPO1 Inhibitor Selinexor Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma Via Nuclear Retention of IκB. Blood. 130. 3837–3837. 1 indexed citations
17.
Kadri, Sabah, Bradley Long, Chao Jie Zhen, et al.. (2016). Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays. Journal of Molecular Diagnostics. 19(1). 43–56. 106 indexed citations
18.
Nayar, Utthara, Pin Lü, Rebecca Goldstein, et al.. (2013). Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies. Blood. 122(16). 2837–2847. 54 indexed citations
19.
Jo, Seung‐Hee, Chunyan Yang, Qi Miao, et al.. (2006). Peroxisome Proliferator-Activated Receptor γ Promotes Lymphocyte Survival through Its Actions on Cellular Metabolic Activities. The Journal of Immunology. 177(6). 3737–3745. 31 indexed citations
20.
Yufit, Tatyana, et al.. (1995). Inhibition of Type I Collagen mRNA Expression Independent of Tryptophan Depletion in Interferon-γ-Treated Human Dermal Fibroblasts. Journal of Investigative Dermatology. 105(3). 388–393. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pearlie K. Epling‐Burnette Breakdown of academic impact, for papers by Alexander Egle Breakdown of academic impact, for papers by John Anastasi Breakdown of academic impact, for papers by Jérôme Tamburini Breakdown of academic impact, for papers by Norma C. Gutiérrez Breakdown of academic impact, for papers by Eric Eldering Breakdown of academic impact, for papers by Lynn C. Moscinski Breakdown of academic impact, for papers by Isabelle Dusanter‐Fourt Breakdown of academic impact, for papers by Mark Blick Breakdown of academic impact, for papers by Keita Kirito
Rankless by CCL
2026